Literature DB >> 19172115

An emerging concept of prion infections as a form of transmissible cerebral amyloidosis.

Omar Lupi1, Marcius Achiame Peryassu.   

Abstract

Proteins are a major constituent of cells with specific biological functions. Besides the primary structure that is simply the sequence of amino acids that comprise a protein, the secondary structure represents the first step of folding defining its general conformation. The biological functions of proteins are directly dependent on the acquisition of their conformation. The same protein can have different stable states, which may participate with different functions in the cell. The amyloid diseases comprise Alzheimer's and Parkinson's diseases, type II diabetes mellitus and systemic amyloidosis. Amyloid fibers are insoluble, resistant to proteolysis and show an extremely high content of beta-sheet, in a very similar structure to the one observed among prion rods, associated to the transmissible spongiform encephalopathies. All these diseases are "infectious" in the sense that misfolded beta-sheeted conformers formed in a nucleation process in which preformed metastable oligomer acts as a seed to convert a normal isoform into an abnormal protein with a misfolded conformation. Only prion infections have a proven infectivity in a microbiological sense; some recent observations, however, detected the transmissibility of systemic amyloidosis by a prion-like mechanism among mice. Prions diseases and amyloidosis present many similar aspects of the so-called conformational diseases; according to this interpretation the prion infections could be considered as a form of transmissible cerebral amyloidosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19172115      PMCID: PMC2634535          DOI: 10.4161/pri.1.4.5816

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  35 in total

1.  Structural studies of the scrapie prion protein by electron crystallography.

Authors:  Holger Wille; Melissa D Michelitsch; Vincent Guenebaut; Surachai Supattapone; Ana Serban; Fred E Cohen; David A Agard; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 2.  The role of chaperone-assisted folding and quality control in inborn errors of metabolism: protein folding disorders.

Authors:  N Gregersen; P Bross; B S Andrese; C B Pedersen; T J Corydon; L Bolund
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

3.  A yeast prion provides a mechanism for genetic variation and phenotypic diversity.

Authors:  H L True; S L Lindquist
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

Review 4.  Prion diseases: a dual view of the prion hypothesis as seen from a distance.

Authors:  Paweł P Liberski; Mariusz Jaskólski
Journal:  Acta Neurobiol Exp (Wars)       Date:  2002       Impact factor: 1.579

Review 5.  Prions in dermatology.

Authors:  Omar Lupi
Journal:  J Am Acad Dermatol       Date:  2002-05       Impact factor: 11.527

6.  Yeast prion protein derivative defective in aggregate shearing and production of new 'seeds'.

Authors:  A S Borchsenius; R D Wegrzyn; G P Newnam; S G Inge-Vechtomov; Y O Chernoff
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

7.  NMR structure of the bovine prion protein.

Authors:  F López Garcia; R Zahn; R Riek; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

8.  Transmissibility of systemic amyloidosis by a prion-like mechanism.

Authors:  Katarzyna Lundmark; Gunilla T Westermark; Sofia Nyström; Charles L Murphy; Alan Solomon; Per Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

Review 9.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

10.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Authors:  Monica Bucciantini; Elisa Giannoni; Fabrizio Chiti; Fabiana Baroni; Lucia Formigli; Jesús Zurdo; Niccolò Taddei; Giampietro Ramponi; Christopher M Dobson; Massimo Stefani
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

View more
  2 in total

1.  Amyloidosis in a Captive Zebra Finch (Taeniopygia guttata) Research Colony.

Authors:  Lisa J Shientag; David S Garlick; Erin Galati
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

2.  A concise review of amyloidosis in animals.

Authors:  Moges Woldemeskel
Journal:  Vet Med Int       Date:  2012-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.